Nuvama Wealth Management Regulatory Approval

Regulatory ApprovalAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Nuvama Wealth Management Regulatory Approval

Nuvama Asset Management, a subsidiary of the company, received SEBI approval to establish a Specialized Investment Fund, enabling the launch of its Numa SIF platform.

Price Movement Clarification

Nuvama Wealth Management Price Movement Clarification

Nuvama Wealth Management replied to a BSE volume-movement surveillance query. The company confirmed no undisclosed event or UPSI exists requiring Regulation 30 disclosure.

Annual General Meeting

Nuvama Wealth Management Annual General Meeting

Nuvama Wealth Management held its 33rd Annual General Meeting on September 28, 2026. The meeting approved standard business resolutions, including the issuance of Non-convertible Debentures.

Share Pledge

Nuvama Wealth Management Share Pledge

PAGAC Ecstasy, a Nuvama promoter, disclosed an increase in underlying loan amounts secured by its existing pledge of 9.69 crore shares (52.57%). No new shares were encumbered.

Employee Stock Options

Nuvama Wealth Management Employee Stock Options

Nuvama Wealth Management has allotted 66,583 equity shares upon the exercise of employee stock options. This issuance follows the company's existing ESOP and ESAR schemes.

Debt & Borrowing

Nuvama Wealth Management Debt & Borrowing: ₹50 Cr

Nuvama Wealth Management has completed the full redemption of its Commercial Papers valued at ₹50 Crore upon maturity. This repayment clears the outstanding debt.

Value

₹50.00 Cr

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.